Last Updated：2025/12/02
CD52, a peptide implicated in certain types of lymphoma, is the target of the monoclonal antibody alemtuzumab.
See correct answer
CD52, a peptide implicated in certain types of lymphoma, is the target of the monoclonal antibody alemtuzumab.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
